The use of single-cell multi-omics in immuno-oncology

Anjun Ma; Gang Xin; Qin Ma

doi:10.1038/s41467-022-30549-4

Nature Communications (May 2022)

The use of single-cell multi-omics in immuno-oncology

Anjun Ma,
Gang Xin,
Qin Ma

Affiliations

Anjun Ma: Department of Biomedical Informatics, The Ohio State University
Gang Xin: Pelotonia Institute for Immuno-Oncology, The James Comprehensive Cancer Center, The Ohio State University
Qin Ma: Department of Biomedical Informatics, The Ohio State University

DOI: https://doi.org/10.1038/s41467-022-30549-4
Journal volume & issue: Vol. 13, no. 1
pp. 1 – 5

Abstract

Read online

Single-cell multi-omics (scMulti-omics) has brought transformative insights into immuno-oncology, demonstrating success in describing novel immune subsets and defining important regulators of antitumor immunity. Here, we give examples of how scMulti-omics has been used in specific tumor studies and discuss how this may develop in the future.

Published in Nature Communications

ISSN: 2041-1723 (Online)
Publisher: Nature Portfolio
Country of publisher: United Kingdom
LCC subjects: Science
Website: https://www.nature.com/ncomms/

About the journal